HY-113764-10mg
|
MedChemexpress LLC
|
N-Butanoyl-DL-homoserine lactone [CAS 98426-48-3]
|
|
COVID-19-anti-virus
|
|
HY-113764-100mg
|
MedChemexpress LLC
|
N-Butanoyl-DL-homoserine lactone [CAS 98426-48-3]
|
|
COVID-19-anti-virus
|
|
HY-113764-25mg
|
MedChemexpress LLC
|
N-Butanoyl-DL-homoserine lactone [CAS 98426-48-3]
|
|
COVID-19-anti-virus
|
|
HY-113764-5mg
|
MedChemexpress LLC
|
N-Butanoyl-DL-homoserine lactone [CAS 98426-48-3]
|
|
COVID-19-anti-virus
|
|
HY-113764-50mg
|
MedChemexpress LLC
|
N-Butanoyl-DL-homoserine lactone [CAS 98426-48-3]
|
|
COVID-19-anti-virus
|
|
HY-P99028-1mg
|
MedChemexpress LLC
|
Ibalizumab [CAS 680188-33-4]
|
|
COVID-19-anti-virus
|
|
HY-P99028-5mg
|
MedChemexpress LLC
|
Ibalizumab [CAS 680188-33-4]
|
|
COVID-19-anti-virus
|
|
HY-P99103-1mg
|
MedChemexpress LLC
|
Bebtelovimab [CAS 2578319-11-4]
|
|
COVID-19-anti-virus
|
|
HY-P99103-10mg
|
MedChemexpress LLC
|
Bebtelovimab [CAS 2578319-11-4]
|
|
COVID-19-anti-virus
|
|
HY-P99103-5mg
|
MedChemexpress LLC
|
Bebtelovimab [CAS 2578319-11-4]
|
|
COVID-19-anti-virus
|
|
HY-P99181-1mg
|
MedChemexpress LLC
|
Mu padolimab [CAS 2451856-97-4]
|
|
COVID-19-anti-virus
|
|
HY-P99181-10mg
|
MedChemexpress LLC
|
Mu padolimab [CAS 2451856-97-4]
|
|
COVID-19-anti-virus
|
|
HY-P99181-5mg
|
MedChemexpress LLC
|
Mu padolimab [CAS 2451856-97-4]
|
|
COVID-19-anti-virus
|
|
HY-P99209-1mg
|
MedChemexpress LLC
|
Motavizumab [CAS 677010-34-3]
|
|
COVID-19-anti-virus
|
|
HY-P99209-10mg
|
MedChemexpress LLC
|
Motavizumab [CAS 677010-34-3]
|
|
COVID-19-anti-virus
|
|
HY-P99209-5mg
|
MedChemexpress LLC
|
Motavizumab [CAS 677010-34-3]
|
|
COVID-19-anti-virus
|
|
HY-P99252-1mg
|
MedChemexpress LLC
|
Itolizumab [CAS 1116433-11-4]
|
|
COVID-19-anti-virus
|
|
HY-P99252-10mg
|
MedChemexpress LLC
|
Itolizumab [CAS 1116433-11-4]
|
|
COVID-19-anti-virus
|
|
HY-P99252-5mg
|
MedChemexpress LLC
|
Itolizumab [CAS 1116433-11-4]
|
|
COVID-19-anti-virus
|
|
HY-P99253-1mg
|
MedChemexpress LLC
|
MogaMu lizumab [CAS 1159266-37-1]
|
|
COVID-19-anti-virus
|
|
HY-P99253-10mg
|
MedChemexpress LLC
|
MogaMu lizumab [CAS 1159266-37-1]
|
|
COVID-19-anti-virus
|
|
HY-P99253-5mg
|
MedChemexpress LLC
|
MogaMu lizumab [CAS 1159266-37-1]
|
|
COVID-19-anti-virus
|
|
HY-P99321-1mg
|
MedChemexpress LLC
|
Teneliximab [CAS 299423-37-3]
|
|
COVID-19-anti-virus
|
|
HY-P99321-10mg
|
MedChemexpress LLC
|
Teneliximab [CAS 299423-37-3]
|
|
COVID-19-anti-virus
|
|
HY-P99321-5mg
|
MedChemexpress LLC
|
Teneliximab [CAS 299423-37-3]
|
|
COVID-19-anti-virus
|
|